Business9 months ago
Swedish Biotech Camurus in Talks to Buy US-Based Braeburn in $1 Billion Opioid Market Bet
Swedish drugmaker Camurus AB is in talks to acquire US-based Braeburn Pharmaceuticals Inc., a move that could strengthen its foothold in the world’s largest market for opioid addiction treatments,...
